Beamtree Holdings Ltd

Beamtree Holdings Ltd

BMT · AU · Healthcare / Health Information Services

0.068AUD-0.00 (-5.56%)

Price History

Full chart

Market Stats

Previous Close0.072
Open0.067
Day Range0.065 – 0.073
52-Week Range0.08 – 0.235
Volume63.95K
Market Cap29.53M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.06
Dividend Yield0.00%
Beta1.25
50-Day Avg0.1143
200-Day Avg0.1382

About

Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally. It operates through four segments: Diagnostic; Clinical Decision Support; Coding & Data Quality Assurance; and Knowledge Networks. The company offers Activity BarCoding, an on-premise solution that captures customized data across organizations to support various operations; Ainsoff Deterioration Index, an application that enables acuity monitoring across the whole organization; operational services in health and social services data analytics; and clinical coding, auditing, education and training services. It also provides PICQ, a quality assessment tool for clinically coded data; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; RippleDown Expert that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; and RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors. In addition, the company offers RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; and workforce wellbeing collaborative program. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. The company was founded in 1996 and is headquartered in North Sydney, Australia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Gareth Pye BCom, CA
  • Employees93
  • Headquarters5 Blue Street, North Sydney, NSW, Australia, 2060, Australia
  • Websitehttps://beamtree.com.au

Leadership

  • Mr. Marek StepniakHead of International
  • Mr. Gareth Pye BCom, CAChief Executive Officer
  • Mr. Neil ThompsonChief Financial Officer
  • Mr. Stephen MorganChief Technology Officer
  • Ms. Kateena MillsHead of People & Culture
  • Ms. Cheryl McCullaghGM of ANZ & Chief Clinical and Innovation Officer
  • Mr. Evan SimmonsHead of Diagnostics Products
  • Ms. Larissa MasonHead of Clinical Decision Support
  • Mr. Stephen BadhamHead of Coding Products
  • Ms. Maria ClementeCompany Secretary

Financials

Income Statement

Currency: AUD2016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue03.05M3.87M294.43K4.12M8.39M16.55M22.77M27.60M28.60M29.19M
Growth (%)--+26.85%-92.40%+1300.90%+103.31%+97.32%+37.60%+21.23%+3.61%+2.08%
Cost of Revenue032.00K50.00K281.38K1.47M5.62M16.75M20.63M22.71M23.69M29.93M
Gross Profit03.02M3.82M13.05K2.65M2.77M-202.00K2.14M4.89M28.60M-738.00K
Gross Margin-98.95%98.71%4.43%64.27%32.98%-1.22%9.39%17.72%100.00%-2.53%
Operating Expense352.75K2.19M1.78M553.84K2.46M3.80M8.45M9.15M5.50M34.83M4.25M
Operating Income-352.75K837.00K2.04M-540.79K188.04K-1.03M-8.65M-7.01M-609.00K-6.23M-4.99M
Operating Margin-27.41%52.66%-183.67%4.56%-12.30%-52.26%-30.80%-2.21%-21.78%-17.09%
EBITDA-1.31M2.10M-744.49K697.11K1.02M-2.28M-1.26M-331.00K-808.00K-4.99M
EBITDA Margin-43.06%54.34%-252.86%16.90%12.16%-13.80%-5.54%-1.20%-2.83%-17.09%
Net Income-352.75K2.54M1.57M-932.36K382.90K-383.62K-4.45M-6.91M-5.11M-6.16M-18.27M
Net Income Margin-83.30%40.63%-316.66%9.28%-4.57%-26.89%-30.34%-18.50%-21.54%-62.59%
R&D---10.95K139.63K507.00K796.00K1.68M2.31M2.96M-
R&D as % of Total Revenue---3.72%3.39%6.05%4.81%7.37%8.35%10.34%-
Interest Expense00025.75K14.29K25.00K56.00K57.00K169.00K239.00K
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.14%0.17%0.15%0.25%0.21%0.59%0.82%

Balance Sheet

Currency: AUD2016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets368.21K5.42M6.97M21.37M32.22M47.05M63.91M62.53M59.65M54.29M37.38M
Total Liabilities60.83K1.45M1.42M1.19M3.01M4.96M15.33M15.31M12.52M12.36M14.03M
Total Equity307.38K3.98M5.55M20.17M29.22M42.09M48.58M47.22M47.14M41.93M23.35M
Cash344.84K1.25M285.00K4.14M4.20M14.12M6.35M8.81M5.04M4.78M2.51M
Total Debt----44.27K799.36K1.12M755.00K1.66M3.26M4.04M
Net Debt--1.25M-285.00K-4.14M-4.16M-13.32M-5.23M-8.05M-3.38M-1.51M1.52M

Cash Flow

Currency: AUD2016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-11.62K922.00K1.99M-1.02M1.05M240.65K-2.32M768.00K-492.00K609.00K931.00K
Investing Cash Flow-35.37K-1.35M-2.96M-15.57M-849.49K-2.98M-5.16M-2.65M-4.02M-2.45M-3.89M
Financing Cash Flow1.08M-1.20M3.00K20.72M-128.49K12.65M-286.00K4.34M749.00K1.58M694.00K
Capital Expenditure35.37K75.00K386.00K119.26K1.07M2.88M2.51M2.65M4.02M2.45M151.00K
Free Cash Flow-847.00K1.61M-1.14M-26.13K-2.64M-4.83M-1.88M-4.51M-1.84M780.00K
Dividends Paid-----109.00K-----
FCF to OCF-91.87%80.64%111.71%-2.50%-1098.00%208.20%-245.18%917.48%-302.96%83.78%
Dividend Paid to FCF------4.13%-----

Earnings

Report DateJun 3, 2019Aug 30, 2019Feb 27, 2020Aug 28, 2020Feb 22, 2021Aug 27, 2021Feb 14, 2022Aug 23, 2022Feb 15, 2023Feb 18, 2025Aug 27, 2025
EPS Estimate0.000.000.000.000.000.000.00--0.000.00
EPS Actual0.01-0.010.000.000.000.00-0.01-0.01-0.02-0.01-0.01
Surprise-----------
Timing------After-hoursAfter-hoursPre-market--

Key Statistics & Ratios

Market Cap29.53M
Enterprise Value31.06M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.01
Price / Book1.26
EPS-0.06
Book Value0.08
Revenue (TTM)29.19M
Gross Profit (TTM)4.01M
EBITDA-3.29M
Profit Margin-62.59%
Operating Margin-10.98%
Return on Equity-55.98%
Return on Assets-6.64%
Shares Outstanding295.34M
Shares Float147.19M
Beta1.25
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%